MAX Sohbet
Promosyon programı Exscientia Holdings Limited
Gelişmiş program
Basit grafik
Temel parametreler
IPO date
2021-10-01
ISIN
US30223G1022
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
gbp
Сайт
Seviye
Hafife alma
| İsim | Anlam | Seviye |
| P/S | 28.18 | 1 |
| P/BV | 1.49 | 9 |
| P/E | 0 | 0 |
Yeterlik
| İsim | Anlam | Seviye |
| ROA | -20.33 | 0 |
| ROE | -33.79 | 0 |
| ROIC | -10.56 | 0 |
Temettüler
| İsim | Anlam | Seviye |
| Temettü getirisi | 0 | 0 |
| DSI | 0 | 0 |
| Ortalama temettü büyümesi | 0 | 0 |
Görev
| İsim | Anlam | Seviye |
| Debt/EBITDA | -0.0861 | 10 |
| Debt/Ratio | 0.2419 | 10 |
| Debt/Equity | 0.3281 | 10 |
Büyüme dürtüsü
| İsim | Anlam | Seviye |
| Hasılat, % | 65.41 | 8 |
| Ebitda, % | 1753.87 | 10 |
| EPS, % | 3263.43 | 10 |
paper.price.prices
| Fiyat | Common.min. | Common.max. | Değiştirmek | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 4.6 $ | 0 $ | 0 $ | -0.4348 % | 0 % | 0 % |
| common.calendar.number_days.7d | 5.3 $ | 0 $ | 0 $ | -13.58 % | 0 % | 0 % |
| common.calendar.number_days.30d | 4.88 $ | 0 $ | 0 $ | -6.15 % | 0 % | 0 % |
| common.calendar.number_days.90d | 5.37 $ | 0 $ | 0 $ | -14.71 % | 0 % | 0 % |
| common.calendar.number_days.180d | 4.97 $ | 0 $ | 0 $ | -7.85 % | 0 % | 0 % |
| common.calendar.number_days.1y | 4.68 $ | 4.26 $ | 6 $ | -2.14 % | 0 % | 0 % |
| common.calendar.number_days.3y | 3.99 $ | 3.99 $ | 12.92 $ | +114.79 % | 0 % | 0 % |
| common.calendar.number_days.5y | 3.99 $ | 3.99 $ | 27.1 $ | +114.79 % | 0 % | 0 % |
| common.calendar.number_days.10y | 3.99 $ | 3.99 $ | 27.1 $ | +114.79 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 6.65 $ | 0 $ | 0 $ | -31.13 % | 0 % | 0 % |
Ana sahipler
ETF'de yer alan
ETF | Paylaşmak, % | Yıllık karlılık, % | Komisyon, % |
| Principal Healthcare Innovators ETF | 0.0252 | -3.92 | 0.35 |
| Future Tech ETF | 0.0252 | 479.5 | 0.35 |
| 0,03 | 237,79 | 0,35 |
|---|
Benzer şirketler
P/E & P/BV
Şirket yönetimi
| Süpervizör | İş unvanı | Ödeme | Doğum yılı |
| Mr. Ben R. Taylor | CFO, Chief Strategy Officer & Executive Director | 531.62k | 1977 (48 yıllar) |
| Ms. Sara Sherman | Vice President of Investor Relations | N/A | |
| Mr. Dan Ireland | Executive VP of Legal & Company Secretary | N/A | |
| Dr. David Hallett Ph.D. | Chief Scientific Officer, Interim CEO, Principal Executive Officer & Executive Director | N/A | 1969 (56 yıllar) |
| Ms. Caroline Rowland | Chief People Officer | N/A | |
| Mr. Richard Law | Chief Business Officer | N/A | |
| Mr. Parker Moss | Executive Vice President of Corporate Development | N/A | |
| Dr. John P. Overington Ph.D. | Chief Technology Officer | N/A | |
| Mr. Nikolaus Krall | Executive Vice President of Precision Medicine | ||
| Dr. Marie-Louise Helena Fjallskog M.D., Ph.D. | Interim Chief Medical Officer & Clinical Development Lead | 1964 (61 yıl) |
Şirket bilgileri
Adres: United Kingdom, Oxford, The SchrOedinger Building - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.exscientia.ai
Web sitesi: https://www.exscientia.ai
Şirket hakkında Exscientia Holdings Limited
Exscientia plc, фармацевтическая компания, основанная на искусственном интеллекте, занимается открытием, проектированием и разработкой лекарств. Он предлагает комплексное решение с использованием искусственного интеллекта и технологий для идентификации целей, разработки кандидатов на лекарства, трансляционных моделей и отбора пациентов. Его платформа позволяет разрабатывать молекулы-кандидаты в лекарственные препараты, а также предоставлять пациентам лекарственную терапию с помощью оценки под руководством ИИ. Компания была основана в 2012 году, ее штаб-квартира находится в Оксфорде, Великобритания.
